Back to the RadioSpace™ home page
NewsDirect story topics:
Consumer, Business & General Interest
Current Events & Public Affairs
Entertainment & Sports
Health & Medicine
Fully produced report in:
mp3PRO format
QuickTime
(MPEG-4/AAC) format
Windows Media Audio
9.2 format
(70 seconds)
-- How Will You Use This Story? --
(OPEN):
THE HEALTH SUBCOMMITTEE, OF THE U-S HOUSE
COMMITTEE ON ENERGY AND COMMERCE, HAS BEEN HOLDING HEARINGS ON
HOW TO ACCELERATE THE DEVELOPMENT OF NEW MEDICINES--INCLUDING
ANTIBIOTICS--IN ORDER TO COMBAT THE THREAT OF MULTIDRUG-RESISTANT
BACTERIAL-INFECTIONS. AMONG THOSE TESTIFYING AT THE HEARINGS IS
DOCTOR BARRY EISENSTEIN ["-STEEN"]--THE SENIOR
VICE-PRESIDENT FOR SCIENTIFIC-AFFAIRS, AT CUBIST
PHARMACEUTICALS...
(EISENSTEIN):
"IN AT LEAST
37 STATES, BACTERIA THAT ARE RESISTANT TO MOST KNOWN-TREATMENTS HAVE
ALREADY BEEN IDENTIFIED. BUT, THE DEVELOPMENT OF ANTIBIOTICS HAS
EXPERIENCED A SHARP-DECLINE: IN FACT, F-D-A-APPROVALS HAVE
DECLINED BY 75-PERCENT--BETWEEN 1983 AND 2007. AND, WHILE
AWARENESS ABOUT THE ISSUE HAS RISEN, LEGISLATIVE-ACTION IS NECESSARY TO
CHANGE COURSE: THE '"GENERATING ANTIBIOTIC INCENTIVES NOW"--OR
"GAIN"--"ACT"' OFFERS OUR BEST-HOPE TO STIMULATE
AMERICAN-INNOVATION, AND TO STRENGTHEN THE HAND OF CLINICIANS AND
SCIENTISTS ALIKE, IN THE FIGHT AGAINST DRUG-RESISTANT PATHOGENS--BOTH
HERE AND ABROAD."
(CLOSE):
FOR MORE INFORMATION, VISIT
"CUBIST"-DOT-COM.
